Podcasts about Lung cancer screening

“A lot of other disease sites, they have some targeted therapies, they have some immunotherapies [IO]. In lung cancer, we have it all. We have chemo. We have IO. We have targeted therapies. We have bispecific T-cell engagers. We have orals, IVs. I think it's just so important now that, particularly for lung cancer, you have to be well versed on all of these,” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer treatment. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by May 16, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer treatments. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episode: Episode 359: Lung Cancer Screening, Early Detection, and Disparities ONS Voice articles: Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Oncology Drug Reference Sheet: Amivantamab-Vmjw Oncology Drug Reference Sheet: Cisplatin Oncology Drug Reference Sheet: Lazertinib Oncology Drug Reference Sheet: Nivolumab and Hyaluronidase-Nvhy Oncology Drug Reference Sheet: Fam-Trastuzumab Deruxtecan-Nxki Optimize Your Testing Strategy and Improve Patient Outcomes With NeoGenomics' Neo Comprehensive™–Solid Tumor Assay Clinical Journal of Oncology Nursing article: Oncogenic-Directed Therapy for Advanced Non-Small Cell Lung Cancer: Implications for the Advanced Practice Nurse ONS Biomarker Database ONS video: What is the role of the KRAS biomarker in NSCLC? Biomarker Testing in Non-Small Cell Lung Cancer Discussion Tool ONS Huddle Cards: Checkpoint inhibitors External beam radiation Monoclonal antibodies Proton therapy To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Unfortunately, because lung cancer is pretty aggressive, we'll see lung cancer mostly in stage IV. So about 50%–55% of all cases are not caught until they are already metastatic, or stage IV. And then about another 25%–30% of cases are caught in stage III, which means they're locally advanced and often not resectable, but we do still treat that with curative intent with concurrent chemoradiation. And then 10%–20% of cases are found in the early stage, and that's stage I and II, where we can do surgical approaches.” TS 2:53 “The majority of radiation that you're going to see is for patients with stage III disease that's inoperable. At my institution, a lot of stage III is inoperable. Now, neoadjuvant immunotherapy has changed that a little bit. But if you have several big, bulky, mediastinal lymph nodes that makes you stage III, surgery is probably not going to be a great option. So we give curative-intent chemoradiation to these patients.” TS 10:51 “Oligoprogression would mean they have metastases but only to one site. And sometimes we will be aggressive with that. Particularly, there's good data, if the only site of progression is in the brain, we can do stereotactic radiation to the brain and then treat the chest with concurrent chemoradiation as a more definitive approach. But outside of that, the majority of stage IV lung cancer is going to be treated with systemic therapy.” TS 15:00 “It's important for nurses to know that there's a lot of different options now for treatment. Probably one of the most important things is making sure patients are aware of what their biomarker status is, what their PD-L1 expression level is, and make sure those tests have been done. … It's good that the patients understand that there's a myriad of options. And a lot of that depends on what we know about their cancer, and then that guides our treatment.” TS 31:05

In this episode of Thinking Thoracic, hear from Alexandra Potter, researcher, and Dr. Chi-Fu Jeffrey Yang, both from Massachusetts General Hospital, about a new study that reveals current lung cancer screening guidelines miss nearly half of patients who develop the disease. Alternative approaches could greatly expand access—especially for women, minorities, and former smokers. 

In this episode, Dr. Mark Meeker, VP and Chief Medical Officer at OSF St. Mary and Holy Family Medical Centers, shares how OSF is using FirstLook Lung, a groundbreaking blood test, to enhance early lung cancer detection—dramatically improving survival outcomes and streamlining care pathways.

In this episode, Dr. Mark Meeker, VP and Chief Medical Officer at OSF St. Mary and Holy Family Medical Centers, shares how OSF is using FirstLook Lung, a groundbreaking blood test, to enhance early lung cancer detection—dramatically improving survival outcomes and streamlining care pathways.

It has been more than a decade since lung cancer screening guidelines via low-dose CT, based on the USPSTF's B recommendations, have been put into place. To discuss the guidelines' ambitions and obstacles, we are joined by the University of Illinois Health System's Mary Pasquinelli, DNP, who specializes in lung cancer, lung cancer screening and pulmonary nodule management. While a lifesaving procedure for at-risk individuals, the uptake of screening on a population-level—though increasing—has been slower than expected. Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast

Episode 359: Lung Cancer Screening, Early Detection, and Disparities “I was actually speaking to a primary care audience back a few weeks ago, and we were talking about lung cancer screening. And they said, ‘Our patients, they don't want to do it.' And I said, ‘Do you remind them that lung cancer is curable?' Because everybody thinks it is a death sentence. But when you're talking about screening a patient, I think it's really important to say, ‘Listen, if we find this early, stage I or stage II, our chances of curing this and it never coming back again is upwards of 60% to 70%,'” ONS member Beth Sandy, MSN, CRNP, thoracic medical oncology nurse practitioner at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a conversation about lung cancer screening. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by April 18, 2027. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to lung cancer screening. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 313: Cancer Symptom Management Basics: Other Pulmonary Complications Episode 295: Cancer Symptom Management Basics: Pulmonary Embolism, Pneumonitis, and Pleural Effusion Episode 247: Tobacco Treatment for Patients With Cancer ONS Voice articles: Lung Cancer Screening and Early Detection Drastically Improves Survival Rates Pack-Year History Is a Biased and Inadequate Criterion for Lung Cancer Screening Eligibility, Researchers Say CMS Expands Eligibility Criteria for Lung Cancer Screening With Low-Dose Computed Tomography Non-Small Cell Lung Cancer Prevention, Screening, Diagnosis, Treatment, Side Effects, and Survivorship Clinical Journal of Oncology Nursing articles: Nurse-Led Tobacco Cessation for Veterans Using Motivational Interviewing in a Lung Cancer Screening Program Identifying Primary Care Patients at High Risk for Lung Cancer: A Quality Improvement Study Oncology Nursing Forum article: Patient–Provider Discussion About Lung Cancer Screening Is Related to Smoking Quit Attempts in Smokers ONS Tobacco, E-Cigarettes, and Vaping Learning Library American Cancer Society Lung Cancer Screening Guidelines American Lung Association lung cancer resources To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “Unfortunately, the current state of lung cancer screening is pretty low. Our rate of uptake in eligible patients is somewhere between 6% and 20%. And that falls much further below what we see for screening, such as breast cancer screening, prostate cancer screening, and colorectal cancer screening. So certainly, we can do better.” TS 1:32 “If you quit more than 15 or 20 years, your risk of developing lung cancer at that point is significantly lower. And so that's why once patients have quit more than 15 years, they're actually not eligible for screening anymore—because their risk of developing lung cancer is dramatically reduced. And that takes into account when you are a primary care provider, pulmonary, whatever field you work in, and you are running a screening clinic each year that you screen the patient, you have to remind yourself when they quit smoking, because once they reach that 15 years, then they're no longer eligible for screening.” TS 5:17 “One of the strategies that they've used to get the word out is, I watch a lot of baseball. I love the Philadelphia Phillies, watch Phillies games. And so at least once a year, maybe even twice a year, they will take an inning of the baseball broadcast on TV and on the radio separately, and they will bring on either an oncologist or pulmonologist from one of the local cancer centers in our area, and the whole inning—between batters of course—they will talk about lung cancer screening and why it's beneficial.” TS 13:16 “Medicare always has its idiosyncrasies. So Medicare—I went over the rules with you, so the age, the smoking. They follow all of it, except they have a slight difference in age. They cover it for age 50 to 77, as opposed to 80.” TS 16:52 “I think just the other thing that people don't think about is that to go get a medical test done, no matter what test it is, typically people have to take time off of work. And it can be really hard to do that when you are relying on your job, maybe you don't have vacation time, maybe you have children at home that you need to get home to. When people are weighing the risk/benefit and thinking, ‘Well, I'd love to get screened for lung cancer, but I just can't find time to fit it into my schedule, and my job won't let me take off.' These are all things that we don't always think about if you have the luxury of just taking the day off.” TS 20:01

Less than 20% of patients eligible for lung cancer screening get screened in the US. A recent study examined whether adults eligible for lung cancer screening engage in screening for other types of cancer. Coauthor Chi-Fu Jeffrey Yang, MD, of Harvard Medical School joins JAMA Deputy Editor Tracy Lieu, MD, to discuss. Related Content: Preventive Health Care Use Among Adults Eligible for Lung Cancer Screening in the US

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning examines how to prevent adverse publicity by patients on social media. Chapters 00:00 Intro 02:01 Patient-Social Media Interaction 11:56 Lung Cancer Screening Recommendations 15:29 Perc vs Surg Revasc, SWEDEHEART Registry 18:06 Down Syndrome Patient Outcomes 19:20 Nighttime Cardiovascular Staffing Impact 23:42 Samurai Cannulation 28:30 Off-Pump AAD Via Upper Ministernotomy 30:35 Robotic Thoracic Truncal Vagotomy 31:59 Upcoming Events 33:02 Closing He explores the benefits and drawbacks of patient groups on social media, explains how social media impacted the Shanghai Pulmonary Hospital, and provides examples of online patient groups. He also discusses whether surgeons should encourage patients to post on social media, what roles surgeons should have in online patient groups, and discusses his own experience with online patient groups.   Joel also reviews recent JANS articles on lung cancer screening and USPSTF recommendations, percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease, outcomes in adult congenital heart disease patients with Down syndrome undergoing a cardiac surgical procedure, and the impact of nighttime cardiovascular intensive care unit staffing on failure to rescue and revenue.   In addition, Joel explores Samurai (the Direct True Lumen Technique) cannulation in acute type I aortic dissection, off-pump aortic arch debranching via upper ministernotomy, and robotic thoracic truncal vagotomy. Before closing, he highlights upcoming events in CT surgery.   JANS Items Mentioned  1.) Lung Cancer Screening and USPSTF Recommendations   2.) Percutaneous vs. Surgical Revascularization of Non-ST-Segment Elevation Myocardial Infarction With Multivessel Disease: The SWEDEHEART Registry  3.) Outcomes in Adult Congenital Heart Disease Patients With Down Syndrome Undergoing a Cardiac Surgical Procedure  4.) Impact of Nighttime Cardiovascular Intensive Care Unit Staffing on Failure to Rescue and Revenue  CTSNET Content Mentioned  1.) Samurai (the Direct True Lumen Technique) Cannulation in Acute Type I Aortic Dissection  2.) Off-Pump Aortic Arch Debranching Via Upper Ministernotomy  3.) Robotic Thoracic Truncal Vagotomy  Other Items Mentioned  1.) Career Center   2.) CTSNet Events Calendar  Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.

In this episode of Inside INdiana Business with Gerry Dick, we explore the transformation of the Indiana State Fairgrounds into a year-round event destination. With 400 events annually—from conventions and sports tournaments to food competitions—the fairgrounds now generate a $330 million economic impact. We take an inside look at the investments fueling this growth and what it means for central Indiana's economy. Plus, Indiana's first-ever mobile lung cancer screening unit hits the road. We'll meet the team behind this 40-foot CT scanner on wheels, designed to bring life-saving early detection directly to Hoosiers in rural areas. Also in this episode: The State Fairgrounds' big sports play: How a state-of-the-art indoor track is attracting national competitions and boosting local revenue. A look inside Jim Irsay's multimillion-dollar collection: From Bob Dylan's electric guitar to Muhammad Ali's iconic fight robe, we go behind the scenes with the Colts owner's world-class artifacts. Indiana's role in March Madness: With 43 postseason college basketball games in Indianapolis this month, we break down the city's economic impact and what's ahead for 2026, when Indy hosts all major NCAA men's championships. The latest in Indiana's auto industry: How tariffs could impact thousands of Honda workers in Greensburg, and what the future holds for the state's manufacturing sector.

In this episode of Inside INdiana Business with Gerry Dick, we explore the transformation of the Indiana State Fairgrounds into a year-round event destination. With 400 events annually—from conventions and sports tournaments to food competitions—the fairgrounds now generate a $330 million economic impact. We take an inside look at the investments fueling this growth and what it means for central Indiana's economy. Plus, Indiana's first-ever mobile lung cancer screening unit hits the road. We'll meet the team behind this 40-foot CT scanner on wheels, designed to bring life-saving early detection directly to Hoosiers in rural areas. Also in this episode: The State Fairgrounds' big sports play: How a state-of-the-art indoor track is attracting national competitions and boosting local revenue. A look inside Jim Irsay's multimillion-dollar collection: From Bob Dylan's electric guitar to Muhammad Ali's iconic fight robe, we go behind the scenes with the Colts owner's world-class artifacts. Indiana's role in March Madness: With 43 postseason college basketball games in Indianapolis this month, we break down the city's economic impact and what's ahead for 2026, when Indy hosts all major NCAA men's championships. The latest in Indiana's auto industry: How tariffs could impact thousands of Honda workers in Greensburg, and what the future holds for the state's manufacturing sector.

This week Bobbi Conner talks with MUSC's Dr. Nichole Tanner about annual lung cancer screening for individuals at an increased risk of lung cancer.

Lung cancer is the leading cause of cancer-related deaths, but early detection can change that. In this episode, Dr. Bill Evans sits down with thoracic surgeon Dr. Christian Finley to discuss the urgent need for lung cancer screening, the latest advancements in early detection, and how a simple, low-dose CT scan can dramatically improve survival rates. DisclaimerThe Cancer Assist Show is hosted by Dr. Bill Evans, MD, FRCP, Past President of the Juravinski Hospital and Cancer Centre at HHS. Brought to you by the Cancer Assistance Program—an organization lending support to cancer patients and families of those affected by cancer. --- The Cancer Assist Show and its content represent the opinions of Dr. Bill Evans and guests to the podcast. Any views and opinions expressed by Dr. Bill Evans and guests are their own and do not represent those of their places of work. The content of The Cancer Assist Show is provided for informational, educational and entertainment purposes only, and is not intended as professional medical, legal or any other advice, or as a substitute or replacement for any such advice. The Cancer Assist Program, Dr. Bill Evans and guests make no representations or warranties with respect to the accuracy or validity of any information or content offered or provided by The Cancer Assist Show. For any medical needs or concerns, please consult a qualified medical professional. No part of The Cancer Assist Show or its content is intended to establish a doctor-patient or any other professional relationship. This podcast is owned and produced by the Cancer Assistance Program.

Lung cancer screening is vital to detecting cancer early, when it is easier to treat and more likely to be cured. Interventional Pulmonologist, Preeti Patel, MD, explains how the screening works and who should be getting this potentially life-saving test.Support the showSarah Bush Lincoln is a 150-bed, not-for-profit, regional health system located in East Central Illinois. Follow us on: Faceboook InstagramLinkedIn

Lung Cancer Screening Guidelines and Care with guest Dr. Lynn Tanoue, November 24, 2024 Yale Cancer Center visit: www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

A traveling, mobile lung screening program has the potential to diagnose cancer earlier, leading to a higher cure rate and lower death rate. In this episode of Thinking Thoracic, STS's new podcast series, host Dr. Jeffrey Yang talks with Dr. Robert Headrick about CHI Memorial's “Breathe Easy” mobile lung screening program and how meeting people where they are with quality healthcare services like this one is saving lives. Learn how to build a mobile lung screening program at a hospital and gain tips on assembling a multidisciplinary team, identifying eligible patient populations, securing funding and the necessary equipment, and more.

A traveling, mobile lung screening program has the potential to diagnose cancer earlier, leading to a higher cure rate and lower death rate. In this episode of Thinking Thoracic, STS's new podcast series, host Dr. Jeffrey Yang talks with Dr. Robert Headrick about CHI Memorial's “Breathe Easy” mobile lung screening program and how meeting people where they are with quality healthcare services like this one is saving lives. Learn how to build a mobile lung screening program at a hospital and gain tips on assembling a multidisciplinary team, identifying eligible patient populations, securing funding and the necessary equipment, and more.

In this episode, we speak with Dr. Natalie Lui, Assistant Professor of Cardiothoracic Surgery at Stanford University, about lung cancer screening and the importance of early detection. Since lung cancer is often diagnosed in advanced stages, yearly low-dose computed tomography (LDCT) screening is crucial, especially for heavy smokers. We discuss risk factors, screening criteria from the U.S. Preventive Services Task Force, National Comprehensive Cancer Network, and the American Cancer Society, and why screening isn't universal despite its importance. Additionally, we explore current research, recent updates to guidelines, barriers to screening in underserved communities, and the potential of emerging technologies, such as AI, to enhance lung cancer screening in the future. Read Transcript CME Information: https://stanford.cloud-cme.com/medcastepisode92 Claim CE: https://stanford.cloud-cme.com/Form.aspx?FormID=3122

With fewer smokers today, the number of Americans getting lung cancer has dropped. However, the decline has been slower in women. Not only are they diagnosed, on average, at a younger age than men, but multiple studies have found that women between the ages of 30 and 49 are developing the disease at higher rates compared to men in the same age group. November is lung cancer awareness month: In this episode, lung cancer experts Brett Bade, MD, and Nagashree Seetharamu, MD, MBBS, join host Sandra Lindsay, RN, to discuss the alarming trend in women and to raise awareness about lung cancer screening in general; currently, less than 10% of people who should be checked for lung cancer actually get screened. Learn the criteria for screening, what the scan is like and how to lower the risk of developing the disease. Read more about this episode on the Northwell Newsroom. Chapters:  02:34 - Lung cancer risk factors 03:32 - Health effects of smoking 04:11 - Second hand smoking 05:14 - Are there early signs of lung cancer?  05:54 - What is lung cancer screening? 07:37 - Low-dose CT lung cancer screening 08:27 - Who is eligible for screening? 08:50 - What if you don't qualify for screening but have a risk factor? 10:31 - What barriers to screening exist? 11:28 - Low screening numbers 12:45 - Lung cancer in young women 14:15 - Sex differences in lung cancer 14:34 - Differences in lung cancer in women 15:41 - EGFR mutation and lung cancer 16:19 - EGFR, Asian woman and lung cancer 17:13 - Breaking down racial disparities 18:49 - Barriers to lung cancer screening About the experts: Dr. Bade is a pulmonologist and the director of the Lung Cancer Screening Program at Lenox Hill Hospital (Patients and providers can call 844-544-5864). Dr. Seetharamu is the head of thoracic and head and neck oncology for Northwell Health. She maintains an active clinical practice at the R.J. Zuckerberg Cancer Center, specializing in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She is also Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Read Dr. Bade's op-ed on lung cancer screening guidelines.

Dr. Leila Rezai explores the updated 10 Pillars of Lung Cancer Screening in light of COPD and Lung Cancer Awareness Month. Dr. Rezai discusses key developments since 2015, including changes in eligibility, the need for patient education, and innovative strategies to enhance screening access. RadioGraphics Update: The 10 Pillars of Lung Cancer Screening—Rationale and Logistics of a Lung CancerScreening Program Adams et al. RadioGraphics 2023; 44(3):e230057.  

Dr. May Lin Tao explains who should be screened for lung cancer, why it's important, and what's involved.

 Lung cancer screenings save lives by detecting cancer early, but only 1.7 percent of eligible Oklahomans get screened. TSET and OU Health are teaming to bring screening to more people by launching a Mobile Lung Cancer Screening bus this fall. Episode 48 provides insights on lung cancer screening from OU Health thoracic surgeon Dr. J. Matthew Reinersman and a person who shares their personal experience with screening, and information on the bus from Terry Rousey, TSET associate director of statewide initiatives.

Prof. Marcus Kennedy, Consultant respiratory physician, Cork University Hospital & President Irish Thoracic society

In this episode we speak with Bellinda King-Kallimanis, PhD, an expert in oncology research and patient advocacy. Bellinda shares her diverse experience in the field, from academia to the FDA and now her role at LUNGevity Foundation. The conversation covers various aspects of lung cancer, including screening procedures, risk factors, and common misconceptions. Bellinda emphasizes the importance of early detection and addresses the stigma associated with lung cancer. We also delve into the Patient-Centered Outcomes Research Institute (PCORI) and a study comparing the impact of using different types of material to communicate screening information to patients. The episode also includes a rapid-fire Q&A section, where Bellinda provides concise explanations of key terms and concepts related to lung cancer. This episode was supported by the Patient Centered Outcomes Research Institute (PCORI) and features this PCORI study by Robert J. Volk, PhD. Key Highlights: 1. Lung cancer screening compliance is strikingly low at 5-6%, despite high risk for those with tobacco history, and additional requirements may further complicate the process. 2. Stigma surrounding lung cancer, primarily due to its association with smoking, can deter people from seeking screening or discussing their health history, despite the fact that people with no tobacco history or people who have not smoked can also develop the disease. 3. Patient involvement in research, through initiatives like citizen science programs, and improved communication of complex information are crucial for advancing lung cancer care and understanding. About our guest: Dr. Bellinda King-Kallimanis is Senior Director of Patient-Focused Research at LUNGevity Foundation. In her work at LUNGevity she aims to ensure that patient and caregiver voices are incorporated in decision making across a wide variety of stakeholders and has built a Citizen Scientist program to aid this. Prior to joining LUNGevity, she worked at the US Food and Drug Administration Oncology Center of Excellence on the Patient Focused Drug Development team. There, she worked on the development and launch of Project Patient Voice, a resource for patients and caregivers along with their healthcare providers to look at patient-reported symptom data collected from cancer clinical trials. Bellinda also has experience in industry and academia and has published over 70 peer-reviewed papers. She received her Bachelor of Social Science and Master of Science in applied statistics from Swinburne University of Technology in Melbourne, Australia, and her PhD in psychometrics from the Academic Medical Center in Amsterdam, Netherlands. Key Moment: At 38:39 “I've taken it on to try to improve my communication as a researcher, because we spend so many years reading complex materials that you just start talking that way. It does not resonate with my family. They'll be like, what are you talking about? Who do you think you are? So if we really want to be able to talk to people and connect the work we do, then we have to be able to talk about it in much simpler terms. I really do think it's so important for us all to work on our abilities to make sure that we are speaking to each other versus, I've been in plenty of conversations where people are not speaking, they're just speaking around each other because there's a gap in the understanding and healthcare is already like very complex and cancer is really scary. So,just being aware of not talking in acronyms all the time.” Visit the ⁠Manta Cares Website⁠ Disclaimer: All content and information provided in connection with Manta Cares is solely intended for informational and educational purposes only.  This content and information is not intended to be a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

Lung cancer is Australia's deadliest cancer. When patients develop symptoms like coughing it is generally no longer curable by surgery or other treatments.The National Lung Cancer Screening Program will begin next year and will involve routine scanning in the hope of catching the disease in its earliest stages. More information, including who's eligible for the Program, is available hereThis podcast is brought to you by Macquarie University Hospital, a part of MQ Health.Professor of Respiratory Medicine at Macquarie University Hospital, Alvin Ing told the MJA the screening program could push the cure rate for lung cancer to as high as 90%,

Lung cancer remains Australia's deadliest cancer. A new screening program, to be introduced in 2025, is expected to save hundreds of lives each year.But for those who have the disease now, how does a multi-disciplinary team work to improve lung cancer care? How are best outcomes created? And how far has Artificial Intelligence and robotic technology evolved in treating this disease?To answer these questions and more, leading Cardiothoracic Surgeon Professor Michael Wilson speaks with The MJA's news and online editor, Sally Block.This podcast is sponsored by Macquarie University Hospital.

Resources provided by podcast participants:National Lung Cancer Round Table-https://nlcrt.org/Lung Plan- https://nlcrt.org/lungplan-overview/Standing Facility Lung Program-https://cancer.wvumedicine.org/about-us/programs/lung-cancer-screening-programMobile Lung Program- https://cancer.wvumedicine.org/about-us/programs/mobile-cancer-screening-program/lucasLiving Beyond Cancer Podcast Series(Patient, Survivors, and Caregivers)-https://cancer.wvumedicine.org/about-us/podcasts/

Howie and Harlan catch up on healthcare headlines, including the politics of treating gun violence as a public health crisis, the growing evidence for the dangers of artificial sweeteners, and the latest on the bird flu outbreak. Links: Aspen Ideas: Health 2024 Harlan Krumholz: “The Next Era of JACC” "First Issue of JACC Debuts Under Harlan M. Krumholz" "U.S. clinical trials begin for twice-yearly HIV prevention injection" UNAIDS: 2023 Fact Sheet Rush University System: Dr. Omar B. Lateef "Rush Signs on as First Partner for Local Laundry Service" “Health Equity as a System Strategy: The Rush University Medical Center Framework” "Surgeon General Declares Gun Violence a Public Health Crisis" Surgeon General's Advisory on Firearm Violence "Surgeon General: Why I'm Calling for a Warning Label on Social Media Platforms" “Patient Navigation for Lung Cancer Screening at a Health Care for the Homeless Program A Randomized Clinical Trial” Vinay Prasad: “CT screening for lung cancer for homeless people: the new JAMA IM paper” Supreme Court: Murthy v. Missouri Opinion "US supreme court allows government to request removal of misinformation on social media" Harlan Krumholz: “Why One Cardiologist Has Drunk His Last Diet Soda" “Xylitol is prothrombotic and associated with cardiovascular risk” "Is Xylitol Dangerous?" CDC: A(H5N1) Bird Flu Response Update June 21, 2024 "Michigan stands out for its aggressive bird flu response. Will other states follow its lead?" "Finland to offer bird flu vaccinations to at-risk residents in a world first" Learn more about the MBA for Executives program at Yale SOM. Email Howie and Harlan comments or questions.

Interview with Priti Bandi, PhD, author of Lung Cancer Screening in the US, 2022, and Ilana B. Richman, MD, MHS, author of Progress in Lung Cancer Screening Adoption. Hosted by Eve Rittenberg, MD. Related Content: Lung Cancer Screening in the US, 2022 Progress in Lung Cancer Screening Adoption

Interview with Priti Bandi, PhD, author of Lung Cancer Screening in the US, 2022, and Ilana B. Richman, MD, MHS, author of Progress in Lung Cancer Screening Adoption. Hosted by Eve Rittenberg, MD. Related Content: Lung Cancer Screening in the US, 2022 Progress in Lung Cancer Screening Adoption

In this podcast, Bahram Mohajer, MD, MPH, explores the study by Park et al. on the use of AI models to automate the evaluation for coronary artery calcification on low-dose lung cancer screening CT scans, as well as the correlation of AI findings with major adverse cardiovascular events. ARTICLE TITLE - Coronary Artery Calcification on Low-Dose Lung Cancer Screening CT in South Korea: Visual and Artificial Intelligence-Based Assessment and Association with Cardiovascular Events

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJP865. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJP865. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJP865. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJP865. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJP865. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJP865. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJP865. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/PJP865. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals In support of improving patient care, this activity has been planned and implemented by PVI, PeerView Institute for Medical Education, and LUNGevity Foundation. PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported by an educational grant from Merck & Co., Inc.Disclosure information is available at the beginning of the video presentation.

This is our 50th episode! Thanks to everyone that has participated as a guest or has watched our videos.In this episode of the 5-Minute Check In with Dr. McGinn, we take a closer look at CommonSpirit Health's updated breast cancer screening guidelines.Topics discussed in this episode include:- Reviewing screening best practices on risk stratification for breast cancer into average, intermediate, and high risk- Screening recommendations - Integrating the criteria into the process of care- Screening approach for patients with high density breast tissueThe episode also includes discussion of the ways in which CommonSpirit is leveraging technology to identify patients eligible for breast cancer screening.Guests:Ankita Sagar, MPH, FACP, System Vice President, Clinical Standards and Variation Reduction, Physician EnterpriseDr. Jessica Croley, Medical Oncologist, Co-lead OCI Breast Clinical Council, CHI St. JosephWatch other cancer screening videos here:Cancer Screening Overview: https://www.youtube.com/watch?v=VESsQ...Lung Cancer Screening: https://youtu.be/5czY2s3PblY?si=KdhYG...Colorectal Cancer Screening: https://youtu.be/CxJbXdGQCQU?si=88oIn...

Dr. Centor discusses the real-world complications of lung cancer screening with Drs. Katharine A. Rendle and Anil Vachani.

CHEST March  2023, Volume 165, Issue 3 Allison C. Welch, MPH, and Jed A. Gorden, MD join CHEST Podcast Moderator, Alice Gallo de Moraes, MD, FCCP, to discuss how American Indian and Alaska Native adults perceive and use lung cancer screening.   DOI: https://doi.org/10.1016/j.chest.2023.10.025   Disclaimer: The purpose of this activity is to expand the reach of CHEST content through awareness, critique, and discussion. All articles have undergone peer review for methodologic rigor and audience relevance. Any views asserted are those of the speakers and are not endorsed by CHEST. Listeners should be aware that speakers' opinions may vary and are advised to read the full corresponding journal article(s) for complete context. This content should not be used as a basis for medical advice or treatment, nor should it substitute the judgment used by clinicians in the practice of evidence-based medicine.

Live and Learn with Katie, Learn Something New! In this impactful video, Katie from MOMnation and Carla from the American Cancer Society come together to raise awareness about the critical importance of early detection and lung cancer screening, especially for individuals who have a history of smoking. Carla courageously shares her personal journey as a lung cancer survivor, shedding light on the challenges she faced and the hope she found through early detection and treatment. As Katie and Carla discuss the sobering statistics surrounding lung cancer, they emphasize the fact that early detection can significantly improve outcomes and save lives. They highlight the American Cancer Society's commitment to providing resources and support for individuals at risk of or affected by lung cancer, including access to screening programs, informational materials, and community networks. - Learn More About the Hope Lodge - https://bit.ly/3uvZwKp - How to Stay Away from Tobacco - https://bit.ly/3HXrlye Carla's firsthand account serves as a powerful reminder of the importance of being proactive about one's health, regardless of past smoking habits. She shares how her decision to undergo a lung cancer screening ultimately led to the detection of the disease at an early stage, enabling her to receive timely treatment and improve her chances of survival. Throughout the video, Katie and Carla underscore the message that no smoker is immune to the risk of lung cancer, and early detection can make all the difference in the fight against this devastating disease. By encouraging viewers to prioritize their health and take advantage of available screening resources, they aim to empower individuals to take control of their well-being and potentially save lives. Don't miss this heartfelt discussion about the importance of early detection and the invaluable support provided by organizations like the American Cancer Society. Join Katie and Carla as they advocate for greater awareness, access to screening, and support for those affected by lung cancer, offering hope and encouragement to viewers everywhere. - Cancer Screening Recommendations - https://bit.ly/49SX6EP - Climb to Conquer Cancer of Phoenix - https://bit.ly/3SDtc07 - Join the MOMnation team for the Climb! - https://fb.me/e/5jfsbzB2y - Online Help - www.cancer.org - Chat live or call 800.227.2345 - The American Cancer Society 24/7 cancer helpline provides information and answers for people dealing with cancer. They can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear. While the American Cancer Society doesn't provide individual financial support, their specialists can help refer individuals to patient-related programs or resources in your local area. Follow and connect with the American Cancer Society: Facebook - https://www.facebook.com/americancancersocietyarizona/ Instagram - https://www.instagram.com/acsarizona/ LinkedIn - https://www.linkedin.com/company/acsarizona YouTube - https://www.youtube.com/amercancersociety X - http://www.twitter.com/americancancer Brought to you by Team EvoAZ at eXp Realty and MOMnation Connect and Follow us at https://direct.me/momnationaz or http://MOMnationUSA.com

Dr. Lauren Kim discusses results from the 20-year follow-up of the International Early Lung Cancer Action Program with Dr. Claudia Henschke, Dr. Rowena Yip, and Dr. David Yankelevitz. A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP). Henschke and Yip et al. Radiology 2023; 309(2):e231988.

Thank you for listening to this episode of "Health and Fitness" from the Nezpod Studios! Enjoy your night or the start of your day, spiced by our top-notch health and fitness/wellness updates coined from the best sources around the globe: made only for your utmost enjoyment and enlightenment… Click on subscribe to get more spicy episodes for free! See you again soon on the next episode of Health and Fitness Updates! Learn more about your ad choices. Visit megaphone.fm/adchoices

The new James mobile lung cancer screening unit is on the road, traveling around the state of Ohio. This is a big step forward because “lung cancer still accounts for more cancer deaths than breast cancer, colon cancer and prostate cancer combined,” said Michael Wert, MD, a James pulmonologist and director of the James lung cancer screening program. “I still see too many patients who haven't seen a doctor in a while, ignore symptoms and come in so sick that we'll do a CT scan and find they have really advanced lung cancer.” In this episode, Wert talks about the goals for the screening unit and why it is so vital. Smoking is the primary cause of lung cancer. “The new screening guidelines for lung cancer are that people aged 50 to 80 with a 20-pack-year history should be screened,” Wert said. “This means someone who has smoked a pack a day for 20 years, or two packs a day for 10 years.” Even people who have quit smoking years ago, but had a 20-pack-year history, need to be screened. “Too many people think what I don't know can't hurt me, but this isn't true, but this fear may prevent people from getting screened,” Wert said. Reaching out to underserved communities is vital in reducing cancer deaths. “Right, now, the major screening centers in Ohio are in the big cities,” Wert said. “And the highest risk patients for lung cancer often lives hours away from the nearest screening facility … We're one of only five or six mobile lung cancer screening units in the country and we're at the cutting edge of this. So, if you live in a remote area, don't be discouraged, our mobile lung cancer screening unit will be coming to you one day and don't let your fears or anxieties of finding an abnormality scare you away. My hope is we'll take our mobile screening unit to a town and hundreds of cars will be lined up waiting for us.”

Susie is joined by Nancy Torreson from A Breath Of Hope Lung Cancer Foundation. They talk about the battle of lung cancer, screening and what we can do better.

11/21/2023 | Lung Cancer Screening

Lung cancer is the second most common cancer in the United States. An estimated 238,340 people in the U.S. will be diagnosed with lung cancer in 2023, and 64% of lung cancers are diagnosed at stage III or IV. With all of these facts, it's surprising that lung cancer screening, a tool that could save lives, is rarely used. Why is that? Who does that impact the most? And what changes can be made? We spoke with Jeff Yang, MD, a thoracic surgeon at Massachusetts General Hospital and founder of the American Lung Cancer Screening Initiative, about symptoms, recommended lung cancer screenings, and available treatment options. We then spoke with Narjust Florez, MD, associate director of the Cancer Care Equity Program and a thoracic medical oncologist at Dana-Farber Cancer Institute, about the stigma and lung cancer patients experience and how patients can better advocate for themselves. Read WebMD Centerpiece: Catching A Killer

Gain valuable insights into the critical importance of lung cancer screening for veterans in this enlightening episode of Hope With Answers Living With Lung Cancer. Explore the unique risks faced by those who have selflessly served our nation. Learn about the occupational hazards, such as asbestos exposure and burn pits, that contribute to the alarming rates of lung cancer among veterans. Delve into the benefits of low-dose CT scans, which can detect lung cancer at earlier stages, potentially leading to more effective treatment options. As LCFA's Breath of Honor: Lung Cancer Screening for Veterans campaign kicks off, join a leading lung cancer specialist and a Navy veteran who is a lung cancer patient as they discuss the need for increased screening and the positive impact it can have on patient outcomes. Discover the curability of smaller tumors, less toxic treatment options, and the hope that lung cancer screening brings to veterans and their families. Guests Drew Moghanaki, MD, UCLA lung cancer specialist and Chief of Thoracic Oncology in the UCLA Department of Radiation Oncology, Co-Director of VA Lung Precision Oncology Program at the Greater Los Angeles VA Healthcare System Jim Pantelas, Navy Veteran, 18-year lung cancer survivor, who has worked for 15 years to increase funding for lung cancer research, improve care for all lung cancer patients, and fight the stigma associated with lung cancer. He is often on Capitol Hill lobbying to increase funding for lung cancer screening and early detection programs. Show Notes | Transcript | Video version “What I would tell vets is that if you're breathing, you can get lung cancer. If you increase the odds of getting lung cancer, which smoking does, then you should be screened. But because you were in the service, you were exposed to toxins, because you were in the service, you were exposed to living in different parts of the country or the world that may have had toxins that you're not aware of. Getting screened is a no-brainer.” – Jim Pantelas Don't miss this opportunity to learn about the latest breakthroughs and the collaborative efforts being made to combat lung cancer among our nation's heroes. Learn the answers to these questions: Why are veterans at a heightened risk for lung cancer? How many veterans are eligible for low-dose CT scans for lung cancer? What are some reasons for hesitancy among veterans to get screened for lung cancer?

Who should be screened for lung cancer? Find out about this and more in today's PV Roundup podcast.